Approach to management of the patient over age 75 with atrial fibrillation.
This article will address the general approach to management of the typical patient >75 years of age with atrial fibrillation. Emphasis will be placed on optimizing the benefit and reducing the risk of anticoagulation in this important and expanding group of patients.
Michelena
H I
HI
Hospital of Saint Raphael, Yale University School of Medicine, New Haven, Connecticut, USA.
Ezekowitz
M D
MD
D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications* / Q000628:therapy*; D006801:Humans; D018570:Risk Assessment; D020521:Stroke / Q000209:etiology* / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin; D001241:Aspirin